Enrichment of circulating melanoma cells (CMCs) using negative selection from patients with metastatic melanoma

Oncotarget

Volumn 5, Issue 9, 2014, Pages 2450-2461

  Joshi, Powrnima ^a   Jacobs, Barbara ^b   Derakhshan, Adeeb ^c   Moore, Lee R ^a   Elson, Paul ^a,b   Triozzi, Pierre L ^b   Borden, Ernest ^b   Zborowski, Maciej ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

^b TAUSSIG CANCER INSTITUTE   (United States)

^c CLEVELAND CLINIC LERNER COLLEGE OF MEDICINE   (United States)

Author keywords

Circulating melanoma cells; CTC; Magnetic separation; Melan A; Negative selection; S100B

Indexed keywords

MELAN A; PROTEIN S100B; CD45 ANTIGEN; MESSENGER RNA; MICRORNA; PTPRC PROTEIN, HUMAN; S100B PROTEIN, HUMAN; TUMOR MARKER;

ADULT; ARTICLE; BLOOD SAMPLING; CANCER STAGING; CANCER SURVIVAL; CENTRIFUGATION; CIRCULATING MELANOMA CELL; CIRCULATING TUMOR CELL; CLINICAL ARTICLE; CONTROLLED STUDY; CUTANEOUS MELANOMA; FEMALE; HEMOLYSIS; HUMAN; HUMAN CELL; IMAGE ANALYSIS; IMMUNOCYTOCHEMISTRY; LEUKOPENIA; MALE; MELANOMA CELL; METASTATIC MELANOMA; MICROSCOPY; SENSITIVITY ANALYSIS; SEPARATION TECHNIQUE; UVEA MELANOMA; BLOOD; CASE CONTROL STUDY; CELL SEPARATION; CHEMISTRY; ENZYME IMMUNOASSAY; GENETICS; IMMUNOMAGNETIC SEPARATION; MELANOMA; PATHOLOGY; PROCEDURES; PROGNOSIS; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SURVIVAL RATE; TUMOR CELL CULTURE; TUMOR EMBOLISM;

ANTIGENS, CD45; BIOMARKERS, TUMOR; CASE-CONTROL STUDIES; CELL SEPARATION; HUMANS; IMMUNOENZYME TECHNIQUES; IMMUNOMAGNETIC SEPARATION; MART-1 ANTIGEN; MELANOMA; MICRORNAS; NEOPLASTIC CELLS, CIRCULATING; PROGNOSIS; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; S100 CALCIUM BINDING PROTEIN BETA SUBUNIT; SURVIVAL RATE; TUMOR CELLS, CULTURED;

EID: 84901218020     PISSN: None     EISSN: 19492553     Source Type: Journal    
DOI: 10.18632/oncotarget.1683     Document Type: Article

References (54)

1. Budd GT, Cristofanilli M, Ellis MJ, Stopeck A, Borden E, Miller MC, Matera J, Repollet M, Doyle GV, Terstappen LW and Hayes DF. Circulating tumor cells versus imaging--predicting overall survival in metastatic breast cancer. Clin Cancer Res. 2006; 12(21):6403-6409.
2. Cristofanilli M, Budd GT, Ellis MJ, Stopeck A, Matera J, Miller MC, Reuben JM, Doyle GV, Allard WJ, Terstappen LW and Hayes DF. Circulating tumor cells, disease progression, and survival in metastatic breast cancer. N Engl J Med. 2004; 351(8):781-791.
3. Riethdorf S, Fritsche H, Muller V, Rau T, Schindlbeck C, Rack B, Janni W, Coith C, Beck K, Janicke F, Jackson S, Gornet T, Cristofanilli M and Pantel K. Detection of circulating tumor cells in peripheral blood of patients with metastatic breast cancer: a validation study of the CellSearch system. Clin Cancer Res. 2007; 13(3):920-928.
4. Cohen SJ, Punt CJ, Iannotti N, Saidman BH, Sabbath KD, Gabrail NY, Picus J, Morse M, Mitchell E, Miller MC, Doyle GV, Tissing H, Terstappen LW and Meropol NJ. Relationship of circulating tumor cells to tumor response, progression-free survival, and overall survival in patients with metastatic colorectal cancer. J Clin Oncol. 2008; 26(19):3213-3221.
5. de Bono JS, Scher HI, Montgomery RB, Parker C, Miller MC, Tissing H, Doyle GV, Terstappen LW, Pienta KJ and Raghavan D. Circulating tumor cells predict survival benefit from treatment in metastatic castration-resistant prostate cancer. Clin Cancer Res. 2008; 14(19):6302-6309.
6. Patel AS, Allen JE, Dicker DT, Peters KL, Sheehan JM, Glantz MJ and El-Deiry WS. Identification and enumeration of circulating tumor cells in the cerebrospinal fluid of breast cancer patients with central nervous system metastases. Oncotarget. 2011; 2(10):752-760.
7. Leary RJ, Kinde I, Diehl F, Schmidt K, Clouser C, Duncan C, Antipova A, Lee C, McKernan K, De La Vega FM, Kinzler KW, Vogelstein B, Diaz LA, Jr. and Velculescu VE. Development of personalized tumor biomarkers using massively parallel sequencing. Sci Transl Med. 2010; 2(20):20ra14.
8. Uzawa K, Baba T, Uchida F, Yamatoji M, Kasamatsu A, Sakamoto Y, Ogawara K, Shiiba M, Bukawa H and Tanzawa H. Circulating tumor-derived mutant mitochondrial DNA: a predictive biomarker of clinical prognosis in human squamous cell carcinoma. Oncotarget. 2012; 3(7):670-677.
9. Diehl F, Schmidt K, Choti MA, Romans K, Goodman S, Li M, Thornton K, Agrawal N, Sokoll L, Szabo SA, Kinzler KW, Vogelstein B and Diaz LA, Jr. Circulating mutant DNA to assess tumor dynamics. Nat Med. 2008; 14(9):985-990.
10. Tibbe AG, de Grooth BG, Greve J, Liberti PA, Dolan GJ and Terstappen LW. Optical tracking and detection of immunomagnetically selected and aligned cells. Nat Biotechnol. 1999; 17(12):1210-1213.
11. Rao C, Bui T, Connelly M, Doyle G, Karydis I, Middleton MR, Clack G, Malone M, Coumans FA and Terstappen LW. Circulating melanoma cells and survival in metastatic melanoma. Int J Oncol. 2011; 38(3):755-760.
12. Balasubramanian P, Lang JC, Jatana KR, Miller B, Ozer E, Old M, Schuller DE, Agrawal A, Teknos TN, Summers TA, Jr., Lustberg MB, Zborowski M and Chalmers JJ. Multiparameter analysis, including EMT markers, on negatively enriched blood samples from patients with squamous cell carcinoma of the head and neck. PloS ONE. 2012; 7(7):e42048.
13. Balasubramanian P, Yang L, Lang JC, Jatana KR, Schuller D, Agrawal A, Zborowski M and Chalmers JJ. Confocal images of circulating tumor cells obtained using a methodology and technology that removes normal cells. Mol Pharm. 2009; 6(5):1402-1408.
14. Tong X, Yang L, Lang JC, Zborowski M and Chalmers JJ. Application of immunomagnetic cell enrichment in combination with RT-PCR for the detection of rare circulating head and neck tumor cells in human peripheral blood. Cytometry Part B, Clinical cytometry. 2007; 72(5):310-323.
15. Yang L, Lang JC, Balasubramanian P, Jatana KR, Schuller D, Agrawal A, Zborowski M and Chalmers JJ. Optimization of an enrichment process for circulating tumor cells from the blood of head and neck cancer patients through depletion of normal cells. Biotechnol Bioeng. 2009; 102(2):521-534.
16. Kopreski MS, Benko FA, Kwak LW and Gocke CD. Detection of tumor messenger RNA in the serum of patients with malignant melanoma. Clin Cancer Res. 1999; 5(8):1961-1965.
17. Gogas H, Eggermont AM, Hauschild A, Hersey P, Mohr P, Schadendorf D, Spatz A and Dummer R. Biomarkers in melanoma. Annals of oncology: official journal of the European Society for Medical Oncology / ESMO. 2009; 20 Suppl 6:vi8-13.
18. Clawson GA, Kimchi E, Patrick SD, Xin P, Harouaka R, Zheng S, Berg A, Schell T, Staveley-O'Carroll KF, Neves RI, Mosca PJ and Thiboutot D. Circulating tumor cells in melanoma patients. PloS one. 2012; 7(7):e41052.
19. Ireland A, Millward M, Pearce R, Lee M and Ziman M. Genetic factors in metastatic progression of cutaneous melanoma: the future role of circulating melanoma cells in prognosis and management. Clin Exp Metastasis. 2011; 28(4):327-336.
20. Yang C and Wei W. The miRNA expression profile of the uveal melanoma. Sci China Life Sci. 2011; 54(4):351-358.
21. Schee K, Boye K, Abrahamsen TW, Fodstad O and Flatmark K. Clinical relevance of microRNA miR-21, miR-31, miR-92a, miR-101, miR-106a and miR-145 in colorectal cancer. BMC Cancer. 2012; 12:505.
22. Catela Ivkovic T, Aralica G, Cacev T, Loncar B and Kapitanovic S. miR-106a overexpression and pRB downregulation in sporadic colorectal cancer. Experimental and molecular pathology. 2013; 94(1):148-154.
23. Luo X, Burwinkel B, Tao S and Brenner H. MicroRNA signatures: novel biomarker for colorectal cancer? Cancer Epidemiol Biomarkers Prev. 2011; 20(7):1272-1286.
24. Asaga S, Kuo C, Nguyen T, Terpenning M, Giuliano AE and Hoon DS. Direct serum assay for microRNA-21 concentrations in early and advanced breast cancer. Clin Chem. 2011; 57(1):84-91.
25. Marusyk A, Almendro V and Polyak K. Intra-tumour heterogeneity: a looking glass for cancer? Nat Rev Cancer. 2012; 12(5):323-334.
26. Khoja L, Lorigan P, Zhou C, Lancashire M, Booth J, Cummings J, Califano R, Clack G, Hughes A and Dive C. Biomarker utility of circulating tumor cells in metastatic cutaneous melanoma. The Journal of investigative dermatology. 2013; 133(6):1582-1590.
27. Allan AL, Vantyghem SA, Tuck AB, Chambers AF, Chin-Yee IH and Keeney M. Detection and quantification of circulating tumor cells in mouse models of human breast cancer using immunomagnetic enrichment and multiparameter flow cytometry. Cytometry A. 2005; 65(1):4-14.
28. Alix-Panabieres C and Pantel K. Circulating tumor cells: liquid biopsy of cancer. Clin Chem. 2013; 59(1):110-118.
29. Dolgin E. New technologies aim to take cancer out of circulation. Nature medicine. 2011; 17(3):266.
30. Gross HJ, Verwer B, Houck D, Hoffman RA and Recktenwald D. Model study detecting breast cancer cells in peripheral blood mononuclear cells at frequencies as low as 10(-7). Proc Natl Acad Sci U S A. 1995; 92(2):537-541.
31. Rosenblatt JI, Hokanson JA, McLaughlin SR and Leary JF. Theoretical basis for sampling statistics useful for detecting and isolating rare cells using flow cytometry and cell sorting. Cytometry. 1997; 27(3):233-238.
32. Coumans FA, Ligthart ST, Uhr JW and Terstappen LW. Challenges in the enumeration and phenotyping of CTC. Clin Cancer Res. 2012; 18(20):5711-5718.
33. Mohamed H, Murray M, Turner JN and Caggana M. Isolation of tumor cells using size and deformation. J Chromatogr A. 2009; 1216(47):8289-8295.
34. Vona G, Sabile A, Louha M, Sitruk V, Romana S, Schutze K, Capron F, Franco D, Pazzagli M, Vekemans M, Lacour B, Brechot C and Paterlini-Brechot P. Isolation by size of epithelial tumor cells: a new method for the immunomorphological and molecular characterization of circulatingtumor cells. Am J Pathol. 2000; 156(1):57-63.
35. Zheng S, Lin H, Liu JQ, Balic M, Datar R, Cote RJ and Tai YC. Membrane microfilter device for selective capture, electrolysis and genomic analysis of human circulating tumor cells. J Chromatogr A. 2007; 1162(2):154-161.
36. Becker FF, Wang XB, Huang Y, Pethig R, Vykoukal J and Gascoyne PR. Separation of human breast cancer cells from blood by differential dielectric affinity. Proc Natl Acad Sci U S A. 1995; 92(3):860-864.
37. Cristofanilli M, Krishnamurthy S, Das CM, Reuben JM, Spohn W, Noshari J, Becker F and Gascoyne PR. Dielectric cell separation of fine needle aspirates from tumor xenografts. J Sep Sci. 2008; 31(21):3732-3739.
38. Jin X, Chalmers JJ and Zborowski M. Iron transport in cancer cell culture suspensions measured by cell magnetophoresis. Anal Chem. 2012; 84(10):4520-4526.
39. Kashevskii BE, Kashevskii SB, Prokhorov IV, Aleksandrova EN and Istomin Iu P. [Magnetophoresis and magnetic susceptibility of HeLa tumor cells]. Biofizika. 2006; 51(6):1026-1032.
40. Hsieh HB, Marrinucci D, Bethel K, Curry DN, Humphrey M, Krivacic RT, Kroener J, Kroener L, Ladanyi A, Lazarus N, Kuhn P, Bruce RH and Nieva J. High speed detection of circulating tumor cells. Biosens Bioelectron. 2006; 21(10):1893-1899.
41. Krivacic RT, Ladanyi A, Curry DN, Hsieh HB, Kuhn P, Bergsrud DE, Kepros JF, Barbera T, Ho MY, Chen LB, Lerner RA and Bruce RH. A rare-cell detector for cancer. Proc Natl Acad Sci U S A. 2004; 101(29):10501-10504.
42. Braun S, Hepp F, Sommer HL and Pantel K. Tumor-antigen heterogeneity of disseminated breast cancer cells: implications for immunotherapy of minimal residual disease. Int J Cancer. 1999; 84(1):1-5.
43. Kasimir-Bauer S, Otterbach F, Oberhoff C, Schmid KW, Kimmig R and Seeber S. Rare expression of target antigens for immunotherapy on disseminated tumor cells in breast cancer patients without overt metastases. Int J Mol Med. 2003; 12(6):969-975.
44. Thurm H, Ebel S, Kentenich C, Hemsen A, Riethdorf S, Coith C, Wallwiener D, Braun S, Oberhoff C, Janicke F and Pantel K. Rare expression of epithelial cell adhesion molecule on residual micrometastatic breast cancer cells after adjuvant chemotherapy. Clin Cancer Res. 2003; 9(7):2598-2604.
45. Yu M, Bardia A, Wittner BS, Stott SL, Smas ME, Ting DT, Isakoff SJ, Ciciliano JC, Wells MN, Shah AM, Concannon KF, Donaldson MC, Sequist LV, Brachtel E, Sgroi D, Baselga J, et al. Circulating breast tumor cells exhibit dynamic changes in epithelial and mesenchymal composition. Science. 2013; 339(6119):580-584.
46. Agus DB, Alexander JF, Arap W, Ashili S, Aslan JE, Austin RH, Backman V, Bethel KJ, Bonneau R, Chen WC, Chen-Tanyolac C, Choi NC, Curley SA, Dallas M, Damania D, Davies PC, et al. A physical sciences network characterization of non-tumorigenic and metastatic cells. Sci Rep. 2013; 3:1449.
47. Baccelli I, Schneeweiss A, Riethdorf S, Stenzinger A, Schillert A, Vogel V, Klein C, Saini M, Bauerle T, Wallwiener M, Holland-Letz T, Hofner T, Sprick M, Scharpff M, Marme F, Sinn HP, et al. Identification of a population of blood circulating tumor cells from breast cancer patients that initiates metastasis in a xenograft assay. Nat Biotechnol. 2013; 31(6):539-544.
48. Chen A, Byvank T, Chang WJ, Bharde A, Vieira G, Miller BL, Chalmers JJ, Bashir R and Sooryakumar R. On-chip magnetic separation and encapsulation of cells in droplets. Lab Chip. 2013; 13(6):1172-1181.
49. Earhart CM, Wilson RJ, White RL, Pourmand N and Wang SX. Microfabricated magnetic sifter for high-throughput and high-gradient magnetic separation. J Magn Magn Mater. 2009; 321(10):1436-1439.
50. Powell AA, Talasaz AH, Zhang H, Coram MA, Reddy A, Deng G, Telli ML, Advani RH, Carlson RW, Mollick JA, Sheth S, Kurian AW, Ford JM, Stockdale FE, Quake SR, Pease RF, et al. Single cell profiling of circulating tumor cells: transcriptional heterogeneity and diversity from breast cancer cell lines. PloS ONE. 2012; 7(5):e33788.
51. Allen JE, Saroya BS, Kunkel M, Dicker DT, Das A, Peters KL, Joudeh J, Zhu J and El-Deiry WS. Apoptotic circulating tumor cells (CTCs) in the peripheral blood of metastatic colorectal cancer patients are associated with liver metastasis but not CTCs. Oncotarget. 2013 Advance Publications.
52. Auer M, Heitzer E, Ulz P, Geigl JB and Speicher MR. Single circulating tumor cell sequencing for monitoring. Oncotarget. 2013; 4(6):812-813.
53. Carvalho FL, Simons BW, Antonarakis ES, Rasheed Z, Douglas N, Villegas D, Matsui W and Berman DM. Tumorigenic potential of circulating prostate tumor cells. Oncotarget. 2013; 4(3):413-421.
54. Quintana E, Piskounova E, Shackleton M, Weinberg D, Eskiocak U, Fullen DR, Johnson TM and Morrison SJ. Human melanoma metastasis in NSG mice correlates with clinical outcome in patients. Sci Transl Med. 2012; 4(159):159ra149.